argenx SE

30
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010832176
EUR
601.80
0.6 (0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
argenx SE Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,088.00
43.00
-303.00
-711.00
-350.00
-540.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-374.00
-300.00
-285.00
-357.00
-288.00
-13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
751.00
26.00
-302.00
-808.00
-511.00
-342.00
Cash Flow from Investing Activities
727.00
-766.00
199.00
-451.00
-295.00
295.00
Cash Flow from Financing Activities
206.00
258.00
1,236.00
802.00
948.00
730.00
Net Cash Inflow / Outflow
1,764.00
-507.00
1,154.00
-508.00
99.00
740.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
78.00
-26.00
21.00
-51.00
-41.00
57.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of argenx SE
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
1088.53269671821
-37.6870000000676
1,125.00
2988.35%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-374.478342221145
-3.85800000000692
-371.00
-9606.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
751.265785022065
-24.1540000000433
775.00
3210.32%
Cash Flow from Investing Activities
727.760984147297
-2.71400000000487
729.00
26915.07%
Cash Flow from Financing Activities
206.463363811553
51.3000000000921
155.00
302.46%
Net Cash Inflow / Outflow
1764.47980308239
24.4180000000438
1,740.00
7126.14%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
78.989670101475
-0.0140000000000251
78.00
564311.93%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 2,711.70% vs 108.82% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
751.27
26.72
2,711.70%